Annie X. Mo

614 total citations
19 papers, 429 citations indexed

About

Annie X. Mo is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Parasitology. According to data from OpenAlex, Annie X. Mo has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 6 papers in Epidemiology and 6 papers in Parasitology. Recurrent topics in Annie X. Mo's work include Malaria Research and Control (8 papers), Mosquito-borne diseases and control (7 papers) and vaccines and immunoinformatics approaches (4 papers). Annie X. Mo is often cited by papers focused on Malaria Research and Control (8 papers), Mosquito-borne diseases and control (7 papers) and vaccines and immunoinformatics approaches (4 papers). Annie X. Mo collaborates with scholars based in United States, Switzerland and Italy. Annie X. Mo's co-authors include Kenneth L. Rock, Bradford Hall, Daniel G. Colley, Ian A. York, Carmela R. Abraham, Tomo Šarić, Wanyong Zeng, Yuelei Shen, Alfred L. Goldberg and Abie Craiu and has published in prestigious journals such as Immunity, Nature Immunology and The Journal of Immunology.

In The Last Decade

Annie X. Mo

19 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie X. Mo United States 11 148 148 114 110 92 19 429
Frank R. Albano Australia 8 91 0.6× 170 1.1× 269 2.4× 43 0.4× 79 0.9× 12 389
Jedidah Mwacharo United Kingdom 12 166 1.1× 229 1.5× 541 4.7× 88 0.8× 67 0.7× 19 865
Joanne M. Chesson Australia 7 153 1.0× 246 1.7× 590 5.2× 111 1.0× 111 1.2× 9 744
Bernard Mbewe Finland 7 107 0.7× 70 0.5× 184 1.6× 53 0.5× 80 0.9× 8 465
Liriye Kurtovic Australia 14 140 0.9× 248 1.7× 394 3.5× 49 0.4× 51 0.6× 18 574
Joanna Hall United Kingdom 7 68 0.5× 146 1.0× 303 2.7× 58 0.5× 101 1.1× 11 430
Madushi Wanaguru United Kingdom 8 150 1.0× 157 1.1× 369 3.2× 43 0.4× 49 0.5× 11 463
L. H. Miller United States 8 66 0.4× 206 1.4× 376 3.3× 76 0.7× 39 0.4× 12 473
Daniela Fusco Germany 10 77 0.5× 76 0.5× 41 0.4× 36 0.3× 278 3.0× 25 471
Hidekazu Ishida Japan 11 83 0.6× 178 1.2× 181 1.6× 100 0.9× 31 0.3× 20 403

Countries citing papers authored by Annie X. Mo

Since Specialization
Citations

This map shows the geographic impact of Annie X. Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie X. Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie X. Mo more than expected).

Fields of papers citing papers by Annie X. Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie X. Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie X. Mo. The network helps show where Annie X. Mo may publish in the future.

Co-authorship network of co-authors of Annie X. Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Annie X. Mo. A scholar is included among the top collaborators of Annie X. Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie X. Mo. Annie X. Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Giersing, Birgitte, Annie X. Mo, Shahida Baqar, et al.. (2025). Meeting summary: Global vaccine and immunization research forum, 2023. Vaccine. 46. 126686–126686. 2 indexed citations
2.
Friedman-Klabanoff, DeAnna, Andrea A. Berry, Mark A. Travassos, et al.. (2024). Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge. The Journal of Infectious Diseases. 229(6). 1883–1893. 2 indexed citations
3.
Singh, Anjali, César Boggiano, Michael A. Eller, et al.. (2023). Optimizing the Immunogenicity of HIV Vaccines by Adjuvants – NIAID Workshop Report. Vaccine. 41(31). 4439–4446. 2 indexed citations
4.
Mo, Annie X., Shahida Baqar, Nancy Touchette, et al.. (2023). Meeting Summary: Global Vaccine and Immunization Research Forum, 2021. Vaccine. 41(11). 1799–1807. 8 indexed citations
5.
Friedman-Klabanoff, DeAnna, Andrea A. Berry, Mark A. Travassos, et al.. (2021). Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing. Vaccine. 39(8). 1195–1200. 16 indexed citations
6.
Mo, Annie X., John Pesce, Alison D. Augustine, et al.. (2020). Understanding vaccine-elicited protective immunity against pre-erythrocytic stage malaria in endemic regions. Vaccine. 38(48). 7569–7577. 9 indexed citations
7.
Mo, Annie X., et al.. (2018). Understanding the Liver-Stage Biology of Malaria Parasites: Insights to Enable and Accelerate the Development of a Highly Efficacious Vaccine. American Journal of Tropical Medicine and Hygiene. 99(4). 827–832. 13 indexed citations
8.
Roestenberg, Meta, Benjamin Mordmüller, Chris Ockenhouse, et al.. (2017). The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016. Vaccine. 35(51). 7065–7069. 14 indexed citations
9.
Roestenberg, Meta, Annie X. Mo, Peter G. Kremsner, & Maria Yazdanbakhsh. (2017). Controlled human infections. Vaccine. 35(51). 7070–7076. 11 indexed citations
10.
Gu, Xin‐Xing, Stanley A. Plotkin, Kathryn M. Edwards, et al.. (2017). Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases. Clinical and Vaccine Immunology. 24(7). 35 indexed citations
11.
Mo, Annie X., John Pesce, & Bradford Hall. (2016). Visceral Leishmaniasis Control and Elimination: Is There a Role for Vaccines in Achieving Regional and Global Goals?. American Journal of Tropical Medicine and Hygiene. 95(3). 514–521. 9 indexed citations
12.
Mo, Annie X. & Daniel G. Colley. (2015). Workshop report: Schistosomiasis vaccine clinical development and product characteristics. Vaccine. 34(8). 995–1001. 29 indexed citations
13.
Mo, Annie X., John Pesce, & Bradford Hall. (2015). Exploring immunological mechanisms of the whole sporozoite vaccination against P. falciparum malaria. Vaccine. 33(25). 2851–2857. 5 indexed citations
14.
Mo, Annie X., Jan M. Agosti, Judd L. Walson, Bradford Hall, & Lance Gordon. (2014). Schistosomiasis Elimination Strategies and Potential Role of a Vaccine in Achieving Global Health Goals. American Journal of Tropical Medicine and Hygiene. 90(1). 54–60. 55 indexed citations
15.
Mo, Annie X. & Alison D. Augustine. (2013). NIAID meeting report: Improving malaria vaccine strategies through the application of immunological principles. Vaccine. 32(10). 1132–1138. 3 indexed citations
16.
Mo, Annie X., Cristina Musselli, Hong Chen, et al.. (2011). A heat shock protein based polyvalent vaccine targeting HSV-2: CD4+ and CD8+ cellular immunity and protective efficacy. Vaccine. 29(47). 8530–8541. 38 indexed citations
17.
Augustine, Alison D., et al.. (2009). NIAID workshop on immunity to malaria: addressing immunological challenges. Nature Immunology. 10(7). 673–678. 16 indexed citations
18.
York, Ian A., Annie X. Mo, Wanyong Zeng, et al.. (2003). The Cytosolic Endopeptidase, Thimet Oligopeptidase, Destroys Antigenic Peptides and Limits the Extent of MHC Class I Antigen Presentation. Immunity. 18(3). 429–440. 113 indexed citations
19.
Mo, Annie X., et al.. (2000). Sequences That Flank Subdominant and Cryptic Epitopes Influence the Proteolytic Generation of MHC Class I-Presented Peptides. The Journal of Immunology. 164(8). 4003–4010. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank R. Albano Breakdown of academic impact, for papers by Jedidah Mwacharo Breakdown of academic impact, for papers by Joanne M. Chesson Breakdown of academic impact, for papers by Bernard Mbewe Breakdown of academic impact, for papers by Liriye Kurtovic Breakdown of academic impact, for papers by Joanna Hall Breakdown of academic impact, for papers by Madushi Wanaguru Breakdown of academic impact, for papers by L. H. Miller Breakdown of academic impact, for papers by Daniela Fusco Breakdown of academic impact, for papers by Hidekazu Ishida
Rankless by CCL
2026